9th Innovative Medicines Initiative (IMI) Call

Last modified: May 21, 2017

Submission deadline passed (July 26th, 2016).

The European Innovative Medicines Initiative (IMI) has launched a Call (Call 9) for proposals on major challenges in drug development. Data quality is one of the focus areas of this Call (Topic 3). Primary aims of this Topic are to boost data quality in medical research by identifying factors that affect data quality, identifying best practices and creating an educational platform. It will focus initially on the fields of neuroscience and preclinical medicines safety. The consortium has a total budget of close on €4.5 million for applicants; this is matched by EFPIA (European Federation of Pharmaceutical Industries and Associations) companies, which pay for their own contribution to address these questions.

The Call is open for submissions from applicant consortia. More information about the topic and how to apply can be found at the IMI website.

NRIN devotes a great deal of attention to the website’s content and would greatly appreciate your suggestions of documents or links you believe to belong on this website.

This selection is an incomplete convenience sample, and does not reflect NRIN’s vision or opinion. Including an item does not necessarily mean that we agree with the authors nor does it imply we think unmentioned items are of poorer quality.

Please report any suggestions, inaccuracies or nonfunctioning hyperlinks etc. that you discover. Thanks in advance!